Larkin, C. (2025). BioMarin to Buy Amicus in $4.8 Billion Bet on Rare Disease Drugs. Bloomberg.com, N.PAG.
Chicago Style (17th ed.) CitationLarkin, Catherine. "BioMarin to Buy Amicus in $4.8 Billion Bet on Rare Disease Drugs." Bloomberg.com 2025: N.PAG.
MLA (9th ed.) CitationLarkin, Catherine. "BioMarin to Buy Amicus in $4.8 Billion Bet on Rare Disease Drugs." Bloomberg.com, 2025, p. N.PAG.
Warning: These citations may not always be 100% accurate.